ModernMedicine Resource Center More Topics


Combination therapy seems best for relief of psoriasis

Combination therapy seems best for relief of psoriasis. Learn about which therapies work in the best combinations for your psoriasis patients.

Treatments for Plaque Psoriasis

Short-term systemic steroids for psoriasis efficacious despite ‘dogma’
Short-term systemic steroids for psoriasis efficacious despite ‘dogma’Data from a recently published study reveal systemic steroids are often the choice of therapy for clinicians based in the US who treat psoriasis, yet this practice is not endorsed in clinical practice guidelines.
Treatment options for psoriasis expanding
Treatment options for psoriasis expandingKey trends among topical treatments for psoriasis include the potential reformulation of systemic therapies into topical form, the search for steroid alternatives and the optimization of vehicles, an expert says.
Psoriasis from the patient's perspective
Psoriasis from the patient's perspectiveA patient with psoriasis asks dermatologists to put themselves in their patients' shoes and look at the condition from that perspective.
Psoriasis stress response in vitro
Psoriasis stress response in vitroRichard D. Granstein, M.D., chairman of dermatology, Weill Cornell Medical College, New York, has conducted research on how the nervous system and, perhaps, stress can make psoriasis worse or control the phenotypic expression of psoriasis.
Psoriasis and comorbidities a worldwide issueThe psychiatric comorbidities associated with psoriasis deserve more attention from physicians around the globe, experts say.
Psoriasis impact goes more than skin deepMany doctors, including dermatologists, would rather not address patients’ feelings about psoriasis. It’s part of how dermatologists protect themselves from bearing the burdens of patients’ woes, according to Richard Fried, M.D., Ph.D., a dermatologist and clinical psychologist in Yardley, Pennsylvania.
Psoriasis in patients with skin of colorPsoriasis in nonwhite patient populations is not well described, according to Andrew F. Alexis, M.D., M.P.H., director of the Skin of Color Center, at St. Luke’s Roosevelt Hospital, Mount Sinai Health System, New York.
Study reveals more side effects of methotrexate
Study reveals more side effects of methotrexateCommon gastrointestinal side effects to methotrexate may include anticipatory, associative and behavioral symptoms, aside from post-treatment nausea and vomiting, according to a new report.
Secukinumab shows superiority to etanercept
Secukinumab shows superiority to etanerceptRecent head-to-head clinical trial results with secukinumab (Novartis) and etanercept (Enbrel, Amgen) show a significant superiority of secukinumab in the treatment and management of patients with moderate-to-severe plaque psoriasis, perhaps heralding a new standard of care for this patient population.
Sustainability of ustekinumab established in patients with psoriatic arthritis
Sustainability of ustekinumab established in patients with psoriatic arthritisThe human interleukin-12 and interleukin-23 (IL-12/IL-23) inhibitor ustekinumab (Stelara, Janssen) is effective and is well tolerated in patients who have active psoriatic arthritis.